Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1293275 Target Snapshot

Eyes absent homolog 2 · SINGLE PROTEIN · Homo sapiens

5,739Compounds
36Assays
1Approved Drugs
36.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O00167. Use UniProt O00167 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O00167 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Eyes absent homolog 2 as ChEMBL target CHEMBL1293275, mapped to UniProt O00167. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Eyes absent homolog 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1293275
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O00167
Protein phosphatase EYA2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Eyes absent homolog 2 is the right protein anchor across sources, using UniProt O00167 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein phosphatase EYA2
UniProt AccessionO00167
Component TypeProtein
Sequence Length538 aa

Protein phosphatase EYA2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Eyes absent homolog 2, mapped to UniProt O00167. ChEMBL maps the protein component as Protein phosphatase EYA2. Sequence length is 538 aa.

Mapped IDO00167
Review nameEyes absent homolog 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
Assay Mix

Activity Type Distribution

IC5036.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4463681 5.75 IC50 1800.0 Preclinical
CHEMBL3191598 5.64 IC50 2300.0 Preclinical
CHEMBL4459891 5.46 IC50 3450.0 Preclinical
CHEMBL4530754 5.4 IC50 4000.0 Preclinical
CHEMBL1975051 5.14 IC50 7300.0 Preclinical
CHEMBL388590 4.99 IC50 10300.0 Approved
CHEMBL3189517 4.78 IC50 16800.0 Preclinical
CHEMBL3190554 4.78 IC50 16800.0 Preclinical
CHEMBL3195222 4.78 IC50 16800.0 Preclinical
CHEMBL4445513 4.78 IC50 16800.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
2
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

36
Total Assays
18
Tested Compounds
2
Assay Types
Binding — 33 assays, 18 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 21 17 4.8
cell-based format 8 0
single protein format 4 1 5.0
Functional — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine